PortfoliosLab logoPortfoliosLab logo
NVDA vs. DFTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NVDA vs. DFTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NVIDIA Corporation (NVDA) and Definium Therapeutics, Inc (DFTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NVDA achieves a 10.16% return, which is significantly lower than DFTX's 84.84% return.


NVDA

1D
0.16%
1M
-12.86%
YTD
10.16%
6M
17.38%
1Y
44.72%
3Y*
71.13%
5Y*
63.13%
10Y*
67.95%

DFTX

1D
2.65%
1M
15.93%
YTD
84.84%
6M
97.21%
1Y
245.19%
3Y*
87.91%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NVDA vs. DFTX - Yearly Performance Comparison


2026 (YTD)2025202420232022
NVDA
NVIDIA Corporation
10.16%38.92%171.25%239.02%-7.68%
DFTX
Definium Therapeutics, Inc
84.84%92.39%90.16%66.36%-78.74%

Correlation

The correlation between NVDA and DFTX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jul 11, 2022

0.24

Fundamentals

Market Cap

NVDA:

$5.00T

DFTX:

$2.69B

EPS

NVDA:

$6.53

DFTX:

-$2.57

PB Ratio

NVDA:

25.60

DFTX:

9.66

Total Revenue (TTM)

NVDA:

$253.49B

DFTX:

$0.00

Gross Profit (TTM)

NVDA:

$187.95B

DFTX:

$0.00

EBITDA (TTM)

NVDA:

$192.76B

DFTX:

-$206.36M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVDA vs. DFTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVDA
NVDA Risk / Return Rank: 7575
Overall Rank
NVDA Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
NVDA Sortino Ratio Rank: 7373
Sortino Ratio Rank
NVDA Omega Ratio Rank: 7171
Omega Ratio Rank
NVDA Calmar Ratio Rank: 7777
Calmar Ratio Rank
NVDA Martin Ratio Rank: 7777
Martin Ratio Rank

DFTX
DFTX Risk / Return Rank: 9696
Overall Rank
DFTX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
DFTX Sortino Ratio Rank: 9595
Sortino Ratio Rank
DFTX Omega Ratio Rank: 9292
Omega Ratio Rank
DFTX Calmar Ratio Rank: 9797
Calmar Ratio Rank
DFTX Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVDA vs. DFTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NVIDIA Corporation (NVDA) and Definium Therapeutics, Inc (DFTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVDADFTXDifference
Sharpe ratioReturn per unit of total volatility

-2.70

Sortino ratioReturn per unit of downside risk

-2.17

Omega ratioGain probability vs. loss probability

1.21

1.46

-0.25

Calmar ratioReturn relative to maximum drawdown

2.07

9.71

-7.64

Martin ratioReturn relative to average drawdown

4.94

30.51

-25.57

NVDA vs. DFTX - Sharpe Ratio Comparison

The current NVDA Sharpe Ratio is 1.20, which is lower than the DFTX Sharpe Ratio of 3.89. The chart below compares the historical Sharpe Ratios of NVDA and DFTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVDA vs. DFTX - Drawdown Comparison

The maximum NVDA drawdown since its inception was -89.72%, roughly equal to the maximum DFTX drawdown of -86.01%. Use the drawdown chart below to compare losses from any high point for NVDA and DFTX.


Loading charts...

Drawdown Indicators


NVDADFTXDifference

Max Drawdown

Largest peak-to-trough decline

-89.72%

-86.01%

-3.71%

Max Drawdown (1Y)

Largest decline over 1 year

-20.21%

-24.79%

+4.58%

Max Drawdown (3Y)

Largest decline over 3 years

-36.88%

-58.38%

+21.50%

Max Drawdown (5Y)

Largest decline over 5 years

-66.34%

Max Drawdown (10Y)

Largest decline over 10 years

-66.34%

Current Drawdown

Current decline from peak

-12.86%

0.00%

-12.86%

Average Drawdown

Average peak-to-trough decline

-36.18%

-51.22%

+15.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.46%

7.93%

+0.53%

Volatility

NVDA vs. DFTX - Volatility Comparison

The current volatility for NVIDIA Corporation (NVDA) is 13.26%, while Definium Therapeutics, Inc (DFTX) has a volatility of 15.21%. This indicates that NVDA experiences smaller price fluctuations and is considered to be less risky than DFTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVDADFTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.26%

15.21%

-1.95%

Volatility (6M)

Calculated over the trailing 6-month period

26.67%

38.79%

-12.12%

Volatility (1Y)

Calculated over the trailing 1-year period

35.00%

61.83%

-26.83%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.76%

83.94%

-32.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.84%

83.94%

-34.10%

Dividends

NVDA vs. DFTX - Dividend Comparison

NVDA's dividend yield for the trailing twelve months is around 0.14%, while DFTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
DFTX
Definium Therapeutics, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.14%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%

Financials

NVDA vs. DFTX - Financials Comparison

This section allows you to compare key financial metrics between NVIDIA Corporation and Definium Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
81.62B
0
(NVDA) Total Revenue
(DFTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NVDA and DFTX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DFTX has higher volatility (15.21%) compared to NVDA (13.26%). In terms of maximum drawdown, NVDA dropped -89.72% vs DFTX's -86.01%.

DFTX currently has the higher Sharpe Ratio (3.89 vs 1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NVDA and DFTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer